In this respect, it seems to be relevant to perform more studies regarding the ESRA V364E variant, a very poorly studied variant that can be determined in patients with ER + BC to prevent vaginal bleeding caused by TAM therapy, which is also a suspicious sign of endometrial cancer. This evidence concerns the gene ESR1 and endometrial cancer.